Nanobiotechnology applications are defined comprehensively as the creation and use of materials, devices and systems through the manipulation of matter at scales of less than 100 nanometres. Globally, Development of efficient and advance technology, technological advancements and rising interest and uses in various industries are the prime growth drivers of global Nanobiotechnology market. In addition, increase in adoption of Nanobiotechnology for pharmaceutical and semiconductors, and emerging economies such as China, India and others, will create new opportunities for global Nanobiotechnology market. However, higher cost of the research and development, and complex manufacturing process are the key restraints for global Nanobiotechnology market.



Geographically North America dominated global Nanobiotechnology market, with approximately half of the world’s procedures being done in the U.S. because of rising nanoparticles used to reinforce tires and other rubber products; photographic silver and dye nanoparticles. Europe is projected to have fastest growth, owing to the favourable growth conditions for pharmaceutical and biotechnology manufacturers due to clinical trial success and eventual Food and Drug Administration (FDA) approval. Among all the applications, neurology segment has the highest market share in global Nanobiotechnology market.

This report identifies the global Nanobiotechnology market size in for the year 2014-2016, and forecast of the same for year 2021. It also highlights the market drivers, restraints, growth indicators, challenges, and other key aspects with respect to global Nanobiotechnology market.

This report segments global Nanobiotechnology market on the basis of type, procedures, and regional market as follows:

Nanobiotechnology Market, By Technology: nanocrystals, nanoparticles, liposomes, micelles, Others
The report has focused study on Nanobiotechnology market by basis of Application: neurology, oncology, cardiovascular/physiology, anti-inflammatory/immunology, anti-infective, Others
This report has been further segmented into major regions, which include detailed analysis of each region such as: North America, Europe, Asia-Pacific (APAC), and Rest of the World (RoW) covering all the major country level markets in each of the region. The major countries considered under the Asia-Pacific region are India, China, South Korea and Japan. The major countries considered under the European region are Germany, U.K., France, Italy, Spain and Russia. The major countries considered under the North American region are United States, Canada and Mexico


This report identifies all the major companies operating in the Nanobiotechnology market. Some of the major companies’ profiles in detail are as follows:

AbbVie, Inc
Amgen, Inc
Celgene Corporation
Johnson & Johnson
Merck & Co., Inc.